Zobrazeno 1 - 5
of 5
pro vyhledávání: '"35"'
Autor:
Gerasimos Aravantinos, Athanasios M. Dimopoulos, Helen Fountzilas, Dimitrios Pectasides, George Fountzilas, Evangelos Bournakis, Ippokratis Korantzis, Paris Kosmidis, George Papaxoinis, Haralabos P. Kalofonos, Pavlos Papakostas, Dimitrios Bafaloukos, Konstantine T. Kalogeras, Angelos Koutras, Dimosthenis Skarlos, Vassiliki Kotoula, Ioannis Varthalitis
Publikováno v:
Oncology Reports.
It is well known that low-dose metronomic chemotherapy has antiangiogenic activity. The aim of the present trial was to investigate the antiangiogenic properties of weekly docetaxel in patients with metastatic breast cancer. In total, 157 metastatic
Autor:
Pierpaolo Maietta, Paolino Papa, Angelina Di Carlo, Daniela Terracciano, Cecere C, Marcello Cicalese, Angela Mariano, Vincenzo Macchia
Publikováno v:
Scopus-Elsevier
The content of carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (Ca 19-9), carbohydrate antigen 15-3 (Ca 15-3) and the expression of Lewis Y related carbohydrate antigens in benign and malignant pleural effusion were determined. These includ
Autor:
Masashi Haraguchi, Ko Komuta, Takashi Kanematsu, Arifumi Akashi, Sumihiro Matsuzaki, Junichiro Furui
Publikováno v:
Oncology Reports.
To investigate the relationship between tumor angiogenesis and hematogenous metastasis in colorectal cancer, an immunohistochemical analysis using antibody against factor VIII was carried out on archival specimens of 35 primary tumors. In addition, w
Autor:
Toshiya Ogawa, Takashi Majima, Takashi Ichikura, Takefumi Uchida, Eiji Okura, Hidetaka Mochizuki
Publikováno v:
Oncology Reports.
Fas ligand (FasL), which induces apoptosis against Fas-expressing cells, has been found to be expressed on various cell types including cancer cells. Membrane-bound FasL is cleaved to release soluble FasL (sFasL). Although serum or plasma sFasL conce
Publikováno v:
Oncology Reports.
The urokinase-type plasminogen activator receptor (uPAR) exists as a GPI anchored glycoprotein (Mr=50-60 kDa) on the surface of various cell types. This receptor can be bound by or cleaved by urokinase. The cleaved receptor, soluble urokinase-type pl